Antiviral Therapy Completion and Response Rates Among Hepatitis C Patients With and Without Schizophrenia

Abstract

Our retrospective chart review suggests that patients with SCHZ complete and respond to antiviral therapy for HCV at rates comparable with those without SCHZ. Based on these data, SCHZ should not be considered a contraindication to antiviral therapy for HCV.